Billiontoone (NASDAQ:BLLN) Stock Price Up 11% – Here’s Why

Billiontoone, Inc. (NASDAQ:BLLN) traded up 11% during mid-day trading on Friday . The stock traded as high as $118.00 and last traded at $115.42. 54,080 shares changed hands during trading, a decline of 72% from the average session volume of 196,165 shares. The stock had previously closed at $104.02.

Analyst Upgrades and Downgrades

A number of analysts have commented on the stock. William Blair assumed coverage on shares of Billiontoone in a research note on Monday. They set an “outperform” rating for the company. Zacks Research upgraded shares of Billiontoone to a “hold” rating in a research report on Tuesday. Wells Fargo & Company initiated coverage on shares of Billiontoone in a research report on Monday. They set an “equal weight” rating and a $110.00 price objective on the stock. Piper Sandler started coverage on Billiontoone in a report on Monday. They issued an “overweight” rating and a $150.00 target price for the company. Finally, Jefferies Financial Group assumed coverage on Billiontoone in a report on Monday. They set a “hold” rating and a $117.00 price target on the stock. Five equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $138.67.

Billiontoone Stock Performance

About Billiontoone

BillionToOne is transforming healthcare by redefining molecular diagnostics. Our revolutionary single molecule NGS (smNGS) platform achieves what was once thought impossible – detecting and precisely quantifying genetic targets with single-molecule sensitivity. At the heart of this technological breakthrough lies our patented QCTs, enabling measurements at the physical limit of detection – the single DNA molecule.